全文获取类型
收费全文 | 28491篇 |
免费 | 2157篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 180篇 |
儿科学 | 565篇 |
妇产科学 | 423篇 |
基础医学 | 3909篇 |
口腔科学 | 522篇 |
临床医学 | 3456篇 |
内科学 | 5242篇 |
皮肤病学 | 260篇 |
神经病学 | 2769篇 |
特种医学 | 1073篇 |
外科学 | 3834篇 |
综合类 | 404篇 |
一般理论 | 30篇 |
预防医学 | 3472篇 |
眼科学 | 694篇 |
药学 | 2088篇 |
中国医学 | 42篇 |
肿瘤学 | 1744篇 |
出版年
2023年 | 159篇 |
2022年 | 289篇 |
2021年 | 612篇 |
2020年 | 385篇 |
2019年 | 565篇 |
2018年 | 642篇 |
2017年 | 497篇 |
2016年 | 532篇 |
2015年 | 700篇 |
2014年 | 915篇 |
2013年 | 1239篇 |
2012年 | 2070篇 |
2011年 | 2052篇 |
2010年 | 1160篇 |
2009年 | 1084篇 |
2008年 | 1846篇 |
2007年 | 1941篇 |
2006年 | 1802篇 |
2005年 | 1760篇 |
2004年 | 1733篇 |
2003年 | 1587篇 |
2002年 | 1460篇 |
2001年 | 394篇 |
2000年 | 308篇 |
1999年 | 357篇 |
1998年 | 311篇 |
1997年 | 230篇 |
1996年 | 229篇 |
1995年 | 182篇 |
1994年 | 184篇 |
1993年 | 150篇 |
1992年 | 262篇 |
1991年 | 225篇 |
1990年 | 206篇 |
1989年 | 225篇 |
1988年 | 198篇 |
1987年 | 191篇 |
1986年 | 170篇 |
1985年 | 185篇 |
1984年 | 156篇 |
1983年 | 146篇 |
1982年 | 95篇 |
1981年 | 86篇 |
1980年 | 85篇 |
1979年 | 109篇 |
1978年 | 94篇 |
1977年 | 87篇 |
1975年 | 74篇 |
1974年 | 86篇 |
1973年 | 81篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
Toidi Adekambi Chris C. Ibegbu Stephanie Cagle Ameeta S. Kalokhe Yun F. Wang Yijuan Hu Cheryl L. Day Susan M. Ray Jyothi Rengarajan 《The Journal of clinical investigation》2015,125(5):1827-1838
BACKGROUND. The identification and treatment of individuals with tuberculosis (TB) is a global public health priority. Accurate diagnosis of pulmonary active TB (ATB) disease remains challenging and relies on extensive medical evaluation and detection of Mycobacterium tuberculosis (Mtb) in the patient’s sputum. Further, the response to treatment is monitored by sputum culture conversion, which takes several weeks for results. Here, we sought to identify blood-based host biomarkers associated with ATB and hypothesized that immune activation markers on Mtb-specific CD4+ T cells would be associated with Mtb load in vivo and could thus provide a gauge of Mtb infection.METHODS. Using polychromatic flow cytometry, we evaluated the expression of immune activation markers on Mtb-specific CD4+ T cells from individuals with asymptomatic latent Mtb infection (LTBI) and ATB as well as from ATB patients undergoing anti-TB treatment.RESULTS. Frequencies of Mtb-specific IFN-γ+CD4+ T cells that expressed immune activation markers CD38 and HLA-DR as well as intracellular proliferation marker Ki-67 were substantially higher in subjects with ATB compared with those with LTBI. These markers accurately classified ATB and LTBI status, with cutoff values of 18%, 60%, and 5% for CD38+IFN-γ+, HLA-DR+IFN-γ+, and Ki-67+IFN-γ+, respectively, with 100% specificity and greater than 96% sensitivity. These markers also distinguished individuals with untreated ATB from those who had successfully completed anti-TB treatment and correlated with decreasing mycobacterial loads during treatment.CONCLUSION. We have identified host blood-based biomarkers on Mtb-specific CD4+ T cells that discriminate between ATB and LTBI and provide a set of tools for monitoring treatment response and cure.TRIAL REGISTRATION. Registration is not required for observational studies.FUNDING. This study was funded by Emory University, the NIH, and the Yerkes National Primate Center. 相似文献
3.
4.
ABSTRACTA monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist. 相似文献
5.
6.
Fluid role boundaries: exploring the contribution of the advanced nurse practitioner to multi‐professional palliative care 下载免费PDF全文
7.
8.
9.
Chris Giles 《Canadian Medical Association journal》2002,167(7):786-787
10.
Ann G Schwartz Geoffrey M Prysak Valerie Murphy Fulvio Lonardo Harvey Pass Jan Schwartz Sam Brooks 《Clinical cancer research》2005,11(20):7280-7287
PURPOSE: A role for estrogens in determining lung cancer risk and prognosis is suggested by reported sex differences in susceptibility and survival. Archival lung tissue was evaluated for the presence of nuclear estrogen receptor (ER)-alpha and ER-beta and the relationship between ER status, subject characteristics, and survival. EXPERIMENTAL DESIGN: Paraffin-embedded lung tumor samples were obtained from 214 women and 64 men from two population-based, case-control studies as were 10 normal lung autopsy samples from patients without cancer. Nuclear ER-alpha and ER-beta expression was determined by immunohistochemistry. Logistic regression was used to identify factors associated with ER positivity and Cox proportional hazards models were used to measure survival differences by ER status. RESULTS: Neither tumor (0 of 94) nor normal (0 of 10) lung tissue stained positive for ER-alpha. Nuclear ER-beta positivity was present in 61% of tumor tissue samples (170 of 278; 70.3% in men and 58.3% in women) and 20% of normal tissue samples (2 of 10; P = 0.01). In multivariate analyses, females were 46% less likely to have ER-beta-positive tumors than males (odds ratio, 0.54; 95% confidence interval, 0.27-1.08). This relationship was stronger and statistically significant in adenocarcinomas (odds ratio, 0.40; 95% confidence interval, 0.18-0.89). Women with ER-beta-positive tumors had a nonsignificant 73% (P = 0.1) increase in mortality, whereas men with ER-beta-positive tumors had a significant 55% (P = 0.04) reduction in mortality compared with those with ER-beta-negative tumors. CONCLUSIONS: This study suggests differential expression by sex and influence on survival in men of nuclear ER-beta in lung cancer, particularly in adenocarcinomas. 相似文献